Evidence map›Paper›PMID 39499184›Full record

ArticleMovement disorders clinical practice2025

Predicting Post-Mortem α-Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia.

Cécilia Tremblay, Charles H Adler, Holly A Shill, Erika Driver-Dunckley, Shyamal Mehta, Parichita Choudhury, Christine Belden, David R Shprecher, Joyce K Lee-Iannotti, Alireza Atri and 2 more

Abstract read
In one paragraph

Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cécilia TremblayDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.ORCID https://orcid.org/0000-0001-8460-7421
Charles H AdlerDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.ORCID https://orcid.org/0000-0002-1045-2743
Holly A ShillDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
Erika Driver-DunckleyDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Shyamal MehtaDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Parichita ChoudhuryDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.ORCID https://orcid.org/0000-0002-8750-1160
Christine BeldenDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
David R ShprecherDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Joyce K Lee-IannottiDepartment of Neurology, Department of Internal Medicine, University of Arizona College of Medicine Phoenix, Phoenix, Arizona, USA.
Alireza AtriDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Geidy E SerranoDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Thomas G BeachDepartement of neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.ORCID https://orcid.org/0000-0003-3296-6128

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
Arizona Biomedical Research CommissionMichael J. Fox Foundation for Parkinson's ResearchNIA NIH HHS P30 AG019610NIA NIH HHS P30AG019610NIA NIH HHS P30 AG072980NIA NIH HHS P30AG072980NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

backgroundIdiopathic rapid eye movement sleep behavior disorder (RBD) is a strong known predictor of a final clinicopathological diagnosis of a Lewy type α-synucleinopathy (LTS). Olfactory dysfunction is an early symptom of synucleinopathies and has been repeatedly associated with the presence of post-mortem LTS.

objectiveTo assess the combined value of a clinician diagnosis of probable RBD (PRBD) and hyposmia in predicting the post-mortem presence of LTS in a broader, less-selected, volunteer elderly population.

methodsWe studied 652 autopsied subjects from the Arizona Study of Aging and Neurodegenerative Disorders, which were evaluated for PRBD, had completed annual movement and cognitive assessments, and had at least one the University of Pennsylvania Smell Identification Test (UPSIT) olfactory test.

resultsHistological evidence of LTS was significantly more frequent in those who had PRBD (112/152: 73.7%) than those without (177/494: 35.8%) (P < 0.001). LTS was more frequent in cases with PRBD and a low UPSIT score (90.8%) compared to cases with PRBD only (73.7%) (P < 0.001) or cases with a low UPSIT score only (69.4%) (P < 0.001). Sensitivity of PRBD diagnosis for predicting LTS was 38.8% and specificity 88.8%, whereas sensitivity of a low UPSIT score was 74.4% and specificity 73.4% (Youden's index = 0.276 for PRBD, 0.478 for UPSIT). When combining both measures, sensitivity was 34.3% and specificity increased to 97.2%.

conclusionPRBD, diagnosed without sleep study confirmation, combined with a reduced olfactory performance is highly specific for predicting post-mortem presence of LTS. The combination of both measures may provide a cost-effective means of predicting LTS in a broader community.

Indexed as

alpha-SynucleinAnosmiaREM Sleep Behavior DisorderSynucleinopathiesAgedAged, 80 and overAutopsyFemaleHumansMaleMiddle Agedalpha-SynucleinMayo sleep questionnaireolfactionParkinson's diseaseREM sleep behavior disorderUPSIT

Identifiers

PMID39499184
PMCPMC11802639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.